Patient-Reported Outcomes Following Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)
- Status
- TERMINATED
- Phase
- PHASE2
Effects of Nonintubated Thoracoscopic Lobectomy on Lung Protection
- Status
- UNKNOWN
- Phase
- NA
Open-label PET Study With [11C]Osimertinib in Patients With EGFRm NSCLC and Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE1
Osimertinib as First-line Therapy for Patients With Late-stage Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
G1T38, a CDK 4/6 Inhibitor, in Combination With Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Explore Prognoses of the Patients With N2 Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A
- Status
- TERMINATED
- Phase
- PHASE3
ALEctinib for the Treatment of Pretreated RET-rearranged Advanced Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Evaluate Effectiveness and Safety of Surgeries in Elderly NSCLC Patients
- Status
- COMPLETED
- Phase
- N/A
A Study to Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Biomarkers of Response to Ipilimumab and Nivolumab in First-line NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
Detecting Radiation-Induced Cardiac Toxicity After Non-Small Cell Lung Cancer Radiotherapy
- Status
- UNKNOWN
- Phase
- N/A
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2